Search by Drug Name or NDC

    NDC 36800-0516-34 topcare tussin CF 20; 200; 10 mg/10mL; mg/10mL; mg/10mL Details

    topcare tussin CF 20; 200; 10 mg/10mL; mg/10mL; mg/10mL

    topcare tussin CF is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Topco Associates LLC. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 36800-0516
    Product ID 36800-516_4072cabb-88fb-472d-b568-d4427286365e
    Associated GPIs 43997303100908
    GCN Sequence Number 000625
    GCN Sequence Number Description guaifen/dextromethorphan/PE LIQUID 100-10-5MG ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 53090
    HICL Sequence Number 000216
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PHENYLEPHRINE
    Brand/Generic Generic
    Proprietary Name topcare tussin CF
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 20; 200; 10
    Active Ingredient Units mg/10mL; mg/10mL; mg/10mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Topco Associates LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 36800-0516-34 (36800051634)

    NDC Package Code 36800-516-34
    Billing NDC 36800051634
    Package 1 BOTTLE in 1 CARTON (36800-516-34) / 237 mL in 1 BOTTLE
    Marketing Start Date 2006-06-12
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL d511afe3-2d53-4ca1-a357-fd947d506f0f Details

    Revised: 5/2022